跳至主要内容
临床试验/IRCT20180712040449N1
IRCT20180712040449N1尚未招募3 期

Formulation and standardization of topical product of Nigella sativa L. and study on its effects in acne vulgaris, a randomized double-blind clinical study

Tehran University of Medical Sciences0 个研究点目标入组 56 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
14 years 至 35 years(—)
性别
All

入选标准

  • Patients between 14–35 years old from both genders
  • Patients with mild to moderate acne as defined by the Investigator’s Global Assessment (IGA) scale
  • Enrolled female participants should have a negative pregnancy test

排除标准

  • Any aesthetic facial procedure including laser therapy and tissue/dermal injectables within the last 6 months
  • Patients having wound and infection on face
  • Patients with any skin disorders that might interfere with the diagnosis or evaluation of acne
  • Very severe acne vulgaris
  • Pregnancy or breastfeeding
  • Patients with any uncontrolled systemic disease
  • Using oral isotretinoin in the last 6 months
  • History of hypersensitivity to blackseed

研究者

相似试验